| Date Filed | Type | Description |
| 04/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/04/2022 |
4
| Pande Atul (Director) has filed a Form 4 on Immunovant, Inc.|
Txns:
| Bought 15,000 shares
@ $5.6, valued at
$84k
|
|
| 08/19/2022 |
4
| Pande Atul (Director) has filed a Form 4 on Immunovant, Inc.|
Txns:
| Granted 21,059 shares
@ $0
Granted 31,668 options to buy
@ $4.99, valued at
$158k
|
|
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2022 |
4
| Pande Atul (Director) has filed a Form 4 on Karuna Therapeutics, Inc.|
Txns:
| Sold 2,500 shares
@ $110.8, valued at
$277k
Exercised 2,500 options to buy
@ $16, valued at
$40k
|
|
| 01/12/2022 |
4
| Pande Atul (Director) has filed a Form 4 on Immunovant, Inc.|
Txns:
| Granted 21,726 shares
@ $0
Granted 71,492 options to buy
@ $7.94, valued at
$567.6k
|
|
| 01/03/2022 |
4
| Pande Atul (Director) has filed a Form 4 on Karuna Therapeutics, Inc.|
Txns:
| Sold 2,500 shares
@ $130.44, valued at
$326.1k
Exercised 2,500 options to buy
@ $16, valued at
$40k
|
|
| 12/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/03/2021 |
4
| Pande Atul (Director) has filed a Form 4 on Karuna Therapeutics, Inc.|
Txns:
| Sold 2,500 shares
@ $136.67, valued at
$341.7k
Exercised 2,500 options to buy
@ $16, valued at
$40k
|
|
| 10/01/2021 |
4
| Pande Atul (Director) has filed a Form 4 on Karuna Therapeutics, Inc.|
Txns:
| Sold 2,500 shares
@ $120.72, valued at
$301.8k
Exercised 2,500 options to buy
@ $16, valued at
$40k
|
|
| 09/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/16/2021 |
4
| Pande Atul (Director) has filed a Form 4 on Immunovant, Inc.|
Txns:
| Bought 5,000 shares
@ $7.98, valued at
$39.9k
|
|
| 08/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2021 |
4
| Pande Atul (Director) has filed a Form 4 on Karuna Therapeutics, Inc.|
Txns:
| Sold 2,500 shares
@ $112.66, valued at
$281.7k
Exercised 2,500 options to buy
@ $16, valued at
$40k
|
|
| 06/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/03/2021 |
4
| Pande Atul (Director) has filed a Form 4 on Karuna Therapeutics, Inc.|
Txns:
| Sold 2,500 shares
@ $120.01, valued at
$300k
Sold 2,500 shares
@ $110.61, valued at
$276.5k
Exercised 2,500 options to buy
@ $16, valued at
$40k
Exercised 2,500 options to buy
@ $16, valued at
$40k
|
|
| 04/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/14/2020 |
4
| Pande Atul (Director) has filed a Form 4 on Karuna Therapeutics, Inc.|
Txns:
| Sold 5,714 shares
@ $92.64, valued at
$529.3k
Exercised 5,714 options to buy
@ $2.92, valued at
$16.7k
|
|
| 11/25/2020 |
4
| Pande Atul (Director) has filed a Form 4 on Sio Gene Therapies Inc.|
Txns:
| Bought 10,000 shares
@ $2.3399, valued at
$23.4k
|
|
| 11/12/2020 |
4
| Pande Atul (Director) has filed a Form 4 on Karuna Therapeutics, Inc.|
Txns:
| Sold 5,000 shares
@ $96.84, valued at
$484.2k
Exercised 5,000 options to buy
@ $2.92, valued at
$14.6k
|
|
| 11/03/2020 |
4
| Pande Atul (Director) has filed a Form 4 on Karuna Therapeutics, Inc.|
Txns:
| Sold 5,000 shares
@ $85, valued at
$425k
Exercised 5,000 options to buy
@ $2.92, valued at
$14.6k
|
|
| 09/18/2020 |
4
| Pande Atul (Director) has filed a Form 4 on Karuna Therapeutics, Inc.|
Txns:
| Sold 5,000 shares
@ $85, valued at
$425k
Exercised 5,000 options to buy
@ $2.92, valued at
$14.6k
|
|
| 08/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/10/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2020 |
4
| Pande Atul (Director) has filed a Form 4 on Karuna Therapeutics, Inc.|
Txns:
| Sold 5,000 shares
@ $93.27, valued at
$466.4k
Exercised 5,000 options to buy
@ $2.92, valued at
$14.6k
|
|
| 06/08/2020 |
4
| Pande Atul (Director) has filed a Form 4 on Karuna Therapeutics, Inc.|
Txns:
| Granted 12,500 options to buy
@ $97.59, valued at
$1.2M
|
|
| 05/18/2020 |
4
| Pande Atul (Director) has filed a Form 4 on Immunovant, Inc.|
Txns:
| Granted 24,700 shares
@ $0
Granted 37,000 options to buy
@ $19.01, valued at
$703.4k
|
|
| 04/17/2020 |
4
| Pande Atul (Director) has filed a Form 4 on Axovant Gene Therapies Ltd.|
Txns:
| Granted 17,500 options to buy
@ $3.45, valued at
$60.4k
|
|
|